Model for estimation of cardiovascular risk in Norway (NORRISK);Modell for estimering av kardiovaskulær risiko i Norge

Tidsskrift for den Norske Laegeforening

Volumn 128, Issue 3, 2008, Pages 286-290

  Selmer, Randi ^a   Lindman, Anja Schou ^b,c   Tverdal, Aage ^b   Pedersen, Jan I ^c   Njølstad, Inger ^d   Veierød, Marit B ^c  

^a Divisjon for Epidemiologi   (Norway)

^b Universitetet I Oslo ^*

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOLOGICAL MODEL; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NORWAY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; SURVIVAL RATE;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; NORWAY; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 38949206601     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Westlund K, Nicolaysen R. Ten-year mortality and morbidity related to serum cholesterol. A follow-up of 3.751 men aged 40-49. Scand J Clin Lab Invest Suppl 1972; 127: 1-24.
2. Pyörälä K, De Backer G, Graham I et al. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis 1994; 110: 121-61.
3. Wood D, De Backer G, Faergeman O et al. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998; 140: 199-270.
4. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998; 19: 1434-503.
5. Conroy RM, Pyörälä K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
6. Graham I, Atar D, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 2007; 14 (suppl 2): E1-E40.
7. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601-10.
8. Otterstad JE, Klemsdal TO, Tverdal A. New European guidelines for cardiovascular prevention. Can they be implemented in Norwegian practice? Oslo: Norsk Cardiologisk Selskap, 2003. www.hjerte.no/?module=Articles&action= ArticleFolder.publicOpenFolder& ID=269 (25.7.2007).
9. Dødsårsaker 2004. www.ssb.no/emner/03/01/10/dodsarsak (25.7.2007).
10. Lindman AS, Selmer R, Tverdal A et al. The SCORE risk model applied to recent population surveys in Norway compared to observed mortality in the general population. Eur J Cardiovasc Prev Rehabil 2006; 13: 731-7.
11. Lindman AS, Veierød MB, Pedersen JI et al. The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway. Eur J Cardiovasc Prev Rehabil 2007; 14: 501-7.
12. Helseregistre og helsestatistikk. www.fhi.no/ artikler/?id=50655 (oppdatert 7.11.2006) (sitert 13.12.2006).
13. Bjartveit K, Foss OP, Gjervig T. The cardiovascular disease study in Norwegian counties. Results from first screening. Acta Med Scand Suppl 1983; 675: 1-184.
14. Tverdal A, Selmer RM. 40-åringsundersøkelsene - 400 000 menn og kvinner har møtt opp. Tidsskr Nor Lægeforen 2002; 122: 2641-2.
15. HeartScore. www.escardio.org/knowledge/decision_tools/heartscore/ (oppdatert 2006) (sitert 13.12.2006).
16. Jenkins JS, Flaker GC, Nolte B et al. Causes of higher in-hospital mortality in women than in men after acute myocardial infarction. Am J Cardiol 1994; 73: 319-22.
17. Getz L, Kirkengen AL, Hetlevik I et al. Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice. A descriptive epidemiological study. Scand J Prim Health Care 2004; 22: 202-8.
18. Getz L, Sigurdsson JA, Hetlevik I et al. Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study. BMJ 2005; 331: 551.
19. Hartz I, Njølstad I, Eggen AE. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. Eur Heart J 2005; 26: 2673-80.
20. Brekke M, Rekdal M, Straand J. Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK). Scand J Prim Health Care 2007; 25: 105-11.